InvestorsHub Logo

ziploc_1

05/24/20 10:17 PM

#276128 RE: Biobillionair #276117

BB...I believe that the judge Du decision on March 30 made the heads of Amarim management spin in the days and weeks after March 30 and discouraged them from initiating a more pro-active campaign to study Vascepa for COVID-19 virus...potentially it can yield at least some anti-inflammatory help to those patients afflicted with early stage COVID-19 infections...just as it provided anti-inflammatory protection against cardiovascular diseases....I am glad that studies are now belatedly getting underway in Canada.